Novartis’s Multiple Sclerosis Pill, a Likely Blockbuster, Gets FDA Approval

As stated on AOL’s Daily Finance page. a new pill for Multiple Sclerosis patients has finally earned approval from the FDA!

The new drug reduces the frequency of relapses and slows the disease’s progression.

See full article from DailyFinance: http://srph.it/cyIwpN

Novartis’s Multiple Sclerosis Pill, a Likely Blockbuster, Gets FDA Approval – DailyFinance.

Like this post? Share it!